Laurenzana, Anna <br/><br/>
Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells.  [electronic resource] 

 -  PloS one  2013 
 - e58267 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0058267  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Caspases--genetics<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--antagonists & inhibitors<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Histones--antagonists & inhibitors<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Male<br/>Mice<br/>Mice, Nude<br/>Prostatic Neoplasms--drug therapy<br/>Tumor Burden--drug effects<br/>Vorinostat<br/>Xenograft Model Antitumor Assays